Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 2126
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 9  |  Issue : 5  |  Page : 2469-2474

The study of placentrex and hydrocortisone as an adjunct treatment in oral submucous fibrosis


1 Consultant Oral and Maxillofacial Surgeon, Mangalmurti Multi Speciality Dental Clinic, Natepute, Maharashtra, India
2 Conservative Dentistry and Endodontics, Government Dental Surgeon, PHC Sampatchak, Patna, Bihar, India
3 Consultant Oral and Maxillofacial Surgeon, Smilecraft Dental Studio, Yelahanka New Town, Banglore, Karnataka, India
4 Intern, Sri Sai College of Dental Surgery, Vikarabad, Telangana, India
5 Consultant Oral and Maxillofacial Surgeon, Jyoti Kendra General Hospital, Ludhiana, Punjab, India
6 Departments of Oral and Maxillofacial Surgery, Dr. H.S.R.S.M Dental College and Hospital, Hingoli, Maharashtra, India
7 Consultant Oral and Maxillofacial Surgeon, Clove Dental and Omni Hospitals, Visakhapatnam, Andhra Pradesh, India

Correspondence Address:
Dr. Vijay Shekhar
Conservative Dentistry and Endodontics, Government Dental Surgeon, PHC Sampatchak, Patna . 800 007, Bihar
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jfmpc.jfmpc_268_20

Rights and Permissions

Background: Submucous fibrosis with a high incidence rate in the Indian subcontinent is a devastating disease affecting the oral cavity and oropharynx. Aims and Objective: To evaluate the efficacy of injection placentrex and injection hydrocortisone in oral submucous fibrosis patients in increasing mouth opening, burning sensation, and improve the mucosal lining. Materials and Methods: We recruited 60 patients with Stage II and Stage III of the ailment, who were randomly divided into Group A and Group B. They were administered submucosal injections of hydrocortisone and placentrex along with physiotherapy and oral iron, nutrients, and B-carotene supplements over a period of 2 months. Interpretations and Results: The pinnacle rate of the incidence was found in the age group of 30 to 40 years among both the genders. Statistically significant difference (P = 0.0001), that is, 5.19 ± 1.33 in Group A and 11.69 ± 1.26 mm in Group B was noted in the mean mouth opening values. Statistically significant difference in burning sensation was noted to be better in Group A than in Group B. Discussion and Conclusion: Overall hydrocortisone seems to be a better regimen for improving the mucosal health and increasing the mouth opening as compared to placentrix regimen. Although Placentrex is better than hydrocortisone in reducing burning sensation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed78    
    Printed2    
    Emailed0    
    PDF Downloaded39    
    Comments [Add]    

Recommend this journal